Dec 11, 2017

5 things that could trip up the spending bill

Trump next to empty seats for Schumer and Pelosi at an aborted spending meeting last month. Photo: Susan Walsh / AP

Sure, Congress wants to go home for the holidays. But it also has to fund the government after Dec. 22. And there are a lot of things that could go wrong.

Here's how plugged-in appropriations experts are ranking the dangers over the next two weeks:

  • Immigration: This is the biggest danger. Democrats will push hard for legal status for the "DREAMers" — people who are in the country illegally who came here as children. And there's no sign that Republicans are willing to put it in the year-end bill. "I don't see how a majority of this Congress leaves without some resolution," said Jim Dyer, a former House Appropriations Committee Republican staff director.
  • No tax deal before the spending bill: If Republicans can't pass a final version of the tax bill by Dec. 22, President Trump could easily pressure Congress to stay in town by refusing to sign a government funding extension until lawmakers finish the tax bill.
  • Defense vs. domestic spending: Democrats could make trouble if a funding bill includes a big boost for defense spending, but nothing for domestic programs.
  • CHIP funding: The Children's Health Insurance Program has expired, and Republicans had said the year-end bill was where its funding would be extended — but they still haven't figured out how to pay for it. Expect pushback from Democrats, and maybe governors, if it doesn't happen.
  • ACA payments: Republican Sen. Susan Collins wants two fixes for the Affordable Care Act — a bipartisan renewal of payments for insurers and a separate set of "reinsurance" funds — as a condition for her to vote for a final tax bill. That could cause problems if the House doesn't go along, which it probably won't.

One more thing: A larger problem, Dyer said, is "the general level of rhetorical excess" — partly driven by the White House.

  • His point: Most of the problems are solvable. It just takes cooler heads.

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3:30 p.m. ET: 838,061 — Total deaths: 41,261 — Total recoveries: 174,115.
  2. U.S.: Leads the world in confirmed cases. Total confirmed cases as of 3:30 p.m. ET: 177,452 — Total deaths: 3,440 — Total recoveries: 6,038.
  3. Public health updates: More than 400 long-term care facilities across the U.S. report patients with coronavirus — Older adults and people with other health conditions are more at risk, new data shows.
  4. Federal government latest: The White House and other institutions are observing several models to better understand and prepare cities for when the coronavirus is expected to peak in the U.S.
  5. In Congress: New York Rep. Max Rose deploys to National Guard to help coronavirus response.
  6. 🎧 Podcast: Misinformation in the coronavirus age.
  7. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk.
  8. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

U.S. coronavirus updates: White House studies models projecting virus peak

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

The White House and other institutions are observing several models to better understand and prepare cities for when the coronavirus is expected to peak in the U.S.

The state of play: The coronavirus is expected to peak in the U.S. in two weeks, but many states like Virginia and Maryland will see their individual peaks well after that, according to a model by the University of Washington's Institute for Health Metrics and Evaluation.

Go deeperArrowUpdated 2 hours ago - Health

FDA authorizes two-minute antibody testing kit to detect coronavirus

Currently, it takes days to produce results from testing kits. Photo: Sergei Malgavko\TASS via Getty Images

The Food and Drug Administration issued an emergency approval Tuesday for a serological testing kit produced by Bodysphere Inc. that can detect a positive or negative result for COVID-19 in two minutes.

Why it matters: Access to testing has improved in the U.S. thanks to commercial labs, but the average wait time for a patient's results is four to five days — with some reports of it taking more than a week.

Go deeperArrowUpdated 2 hours ago - Health